Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT01566305
Eligibility Criteria:
Inclusion Criteria:
* Aged between 18 and 70 years
* Fasting serum total cholesterol between 5.5 - 8.0 mmol/l
* Fasting plasma glucose \< 7.0 mmol/l
* BMI between 25-30 kg/m2
* non-smoking
* Willingness to abstain for the duration of the study from egg consumption
Exclusion Criteria:
* unstable body weight (weight gain or loss \>3 kg in the past 3 months)
* allergic for eggs or egg-rich products
* allergic or intolerant for cow-milk (lactose) based products
* indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus
* use of medication or a diet known to affect serum lipid or glucose metabolism - active cardiovascular disease (for instance congestive heart failure) or recent (\<6 months) event, such as acute myocardial infarction or cerebro-vascular accident
* not willing to stop the consumption of vitamin supplements, fish oil capsules or products rich in plant stanol or sterol esters 3 weeks before the start of the study
* men: consumption of \>21 alcohol consumptions a week
* women: consumption of \>14 alcohol consumptions a week
* abuse of drugs
* pregnant or breastfeeding women
* participation in another biomedical study within 1 month prior to the screening visit
* having donated blood (as blood donor) within 1 month prior to the screening visit or planning to do so during the study
* impossible or difficult venipuncture as evidenced during the screening visits
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01566305
Study Brief:
Protocol Section:
NCT01566305